| Literature DB >> 28983169 |
Haitham A Badran1, M A Abdelhamid1, Mazen T Ibrahim1, Ayman M Abdelmoteleb1, John K Zarif1.
Abstract
BACKGROUND: Cardiac resynchronization therapy (CRT) is an established treatment for patients with advanced heart failure that results in improvement of left ventricle (LV) systolic function and LV reverse remodeling. This may have a positive effect on the size and the function of the left atrium (LA). We assessed the LA function, dimensions, and volumes before and after CRT implantation.Entities:
Keywords: Cardiac resynchronization therapy; Left atrium; Reverse remodeling
Year: 2017 PMID: 28983169 PMCID: PMC5623035 DOI: 10.1016/j.jsha.2017.01.008
Source DB: PubMed Journal: J Saudi Heart Assoc ISSN: 1016-7315
Figure 1Showing improvement in left atrium longitudinal strain in a group A patient after cardiac resynchronization therapy (lower panel) compared to baseline (upper panel).
Baseline demographic, clinical, electrocardiographic, and echocardiographic data in both study groups.
| Responders | Nonresponders | ||
|---|---|---|---|
| Age | 56 ± 9.8 | 53 ± 9.5 | NS |
| Male sex | 17 (70.8%) | 9 (69.2%) | NS |
| HF etiology | |||
| Dilated cardiomyopathy | 19 (79%) | 10 (76.9%) | NS |
| Ischemic cardiomyopathy | 5 (20.8%) | 3 (23%) | NS |
| New York Heart | |||
| III | 16 (66.6%) | 7 (53.8%) | NS |
| IV | 8 (33.3%) | 6 (46%) | NS |
| MLHFQ | 61.8 ± 12.34 | 65.63 ± 20.49 | NS |
| ACEI/ARB | 23 (95.8%) | 13 (100%) | NS |
| Β-blockers | 22 (91.6%) | 12 (92.3%) | NS |
| Spironolactone/eplerenone | 23 (95.8%) | 13 (100%) | NS |
| 2D echo and TDI | |||
| LV EDV | 255.5 ± 74.76 | 251.13 ± 66.96 | NS |
| LV ESV | 192 ± 67 | 194.13 ± 58.18 | NS |
| LV EF % | 25.44 ± 7.4 | 23.63 ± 6.48 | NS |
| E wave | 0.63 ± 0.18 | 0.69 ± 0.13 | NS |
| A wave | 0.67 ± 0.24 | 0.4 ± 0.17 | 0.01 |
| E/A | 1.14 ± 0.66 | 2.11 ± 1.07 | NS |
| E′ | 0.06 ± 0.14 | 0.06 ± 0.13 | NS |
| E/E′ | 10.59 ± 2.89 | 10.69 ± 3.33 | NS |
| TDI SD | 44.72 ± 5.98 | 43 ± 19.39 | NS |
| LA diameter | 43.88 ± 1.82 | 50.3 ± 5.8 | <0.001 |
| LA Vmax | 73.04 ± 21.78 | 104.89 ± 30.93 | <0.001 |
| LA Vmin | 41.8 ± 13.97 | 71.75 ± 28.67 | <0.001 |
| LA Vmax index | 37.1 ± 10.72 | 52.08 ± 12.36 | <0.05 |
| LAEF | 41.99 ± 13.9 | 31.3 ± 16.29 | NS |
| Global LA + ve strain | 12.45 ± 6.12 | 8.35 ± 6.87 | NS |
| Global LA −ve strain | −1.62 ± 1.2 | −1.34 ± 0.74 | NS |
QRS width in ms; LV ESV, EDV in mL, E, E′, and A in m/s; LA diameter in mm, Vmax and Vmin in mL.
A = late diastolic mitral inflow velocity; ACEI = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker; E = early diastolic mitral inflow velocity; E′ = early diastolic mitral annular velocity; EDV = end-diastolic volume; EF = ejection fraction; ESV = left ventricular end-systolic volume; LA = left atrium; LV = left ventricle; TDI = tissue Doppler imaging; Vmax = maximal volume; Vmin = minimal volume.
Clinical, electrocardiogram and left ventricle echocardiographic data 3 months after cardiac resynchronization therapy.
| Responders | Nonresponders | ||
|---|---|---|---|
| New York Heart Association class | |||
| I&II | 22 (91.6%) | 0 | <0.001 |
| III&IV | 2 (8.4%) | 13 (100%) | <0.001 |
| MLHFQ | 25.6 ± 13 | 63.6 ± 18.2 | <0.001 |
| QRS width | 129.7 ± 10.2 | 143.5 ± 13.3 | <0.001 |
| 2D echo and TDI | |||
| LV EDV | 221.5 ± 73.1 | 260.9 ± 65.7 | NS |
| LV ESV | 141.19 ± 47.79 | 202.4 ± 57.5 | 0.01 |
| EF % | 34.7 ± 8 | 24.13 ± 6.4 | 0.004 |
| E wave | 0.58 ± 0.15 | 0.69 ± 0.2 | NS |
| A wave | 0.81 ± 0.18 | 0.42 ± 0.16 | <0.001 |
| E/A | 0.7 ± 0.14 | 1.95 ± 0.96 | <0.001 |
| E′ | 0.06 ± 0.14 | 0.06 ± 0.13 | NS |
| E/E′ | 10.59 ± 2.89 | 10.69 ± 3.33 | NS |
| TDI SD | 32.5 ± 6.6 | 42.7 ± 16.4 | <0.01 |
QRS width in ms; LVESV, EDV in mL; E, E′, and A in m/s.
A = late diastolic mitral inflow velocity; E = early diastolic mitral inflow velocity; E′ = early diastolic mitral annular velocity; EDV = end-diastolic volume; EF = ejection fraction; ESV = left ventricular end-systolic volume; LA = left atrium; LV = left ventricle; MLHFQ = Minnesota Living with Heart Failure Questionnaire; TDI = tissue Doppler imaging; Vmax = maximal volume; Vmin = minimal volume.
Left atrial (LA) dimensions and function in both study groups before and after cardiac resynchronization therapy.
| Group A before | Group A after | % | Group B before | Group B after | % | |||
|---|---|---|---|---|---|---|---|---|
| LA diameter | 43.88 ± 1.82 | 41.6 ± 1.67 | −5.20 ± 0.42 | <0.01 | 50.3 ± 5.8 | 51 ± 5.7 | 1.39 ± 0.32 | NS |
| LA Vmax | 73.04 ± 21.7 | 62.2 ± 18.3 | −14.84 ± 8.78 | <0.01 | 104.89 ± 30.93 | 113.3 ± 24.6 | 8.02 ± 4.11 | NS |
| LA Vmin | 41.8 ± 13.97 | 32.6 ± 12.3 | −22.01 ± 15.66 | <0.01 | 71.75 ± 28.67 | 77.4 ± 26.2 | 7.87 ± 5.81 | NS |
| LA Vmax index | 37.1 ± 10.72 | 32.1 ± 12.7 | −13.48 ± 9.23 | <0.01 | 52.08 ± 12.36 | 56.6 ± 10.5 | 8.68 ± 3.67 | NS |
| LA EF | 41.99 ± 13.9 | 48.3 ± 11.3 | 15.03 ± 8.49 | NS | 31.3 ± 16.29 | 31.8 ± 17.1 | 1.60 ± 1.69 | NS |
| Global LA +ve strain | 12.45 ± 6.12 | 16.6 ± 5.89 | 33.33 ± 28.21 | <0.01 | 8.35 ± 6.87 | 5.38 ± 2.19 | −35.57 ± 43.74 | NS |
| Global LA −ve strain | −1.62 ± 1.2 | −3.3 ± 1.9 | 103.70 ± 136.3 | <0.01 | −1.34 ± 0.74 | −0.99 ± 0.62 | −26.12 ± 30.78 | NS |
LA diameter in mm, Vmax and Vmin in mL.
EF = ejection fraction; LA = left atrium; Vmax = maximal volume; Vmin = minimal volume.
Figure 2Reduction in left atrium diameter after cardiac resynchronization therapy in the same patient (right panel) compared to baseline (left panel).
Figure 3Reduction of left atrium area in apical four-chamber view.
Correlation between different variables before cardiac resynchronization therapy and percent of change in left ventricular end-systolic volume after cardiac resynchronization therapy.
| LA Vmax index | −0.409 | 0.013 |
| LA Vmax | −0.496 | 0.002 |
| LA Vmin | −0.522 | 0.001 |
| LA diameter | −0.539 | 0.001 |
| LA EF | 0.129 | NS |
| A wave | 0.524 | 0.001 |
| E/A | −0.500 | 0.002 |
E A = late diastolic mitral inflow velocity; E = early diastolic mitral inflow velocity; EF = ejection fraction; LA = left atrium; Vmax = maximal volume; Vmin = minimal volume.
Figure 4Scatter plot showing negative correlation between percent of left ventricle end-systolic volume (LVESV) change after cardiac resynchronization therapy and left atrium (LA) maximal volume (upper panel) and left atrium diameter before cardiac resynchronization therapy (lower panel).
Independent predictors of response to cardiac resynchronization therapy after 3 months.
| Odds ratio | 95% CI | COV | Sensitivity | Specificity | |||
|---|---|---|---|---|---|---|---|
| A wave | 0.077 | 1.05–1.37 | ≥0.465 | 87.5 | 75 | 0.0133 | |
| E/A | 0.2320 | 0.0670–0.8032 | ≤1.39 | 75 | 87.5 | 0.0211 | |
| LA diameter before | 0.4605 | 0.2522–0.8410 | ≤47.5 | 100 | 75 | 0.0116 | |
| LA Vmax before | 0.9378 | 0.8923–0.9856 | ≤90.7 | 93.8 | 75 | 0.0113 | |
| LA Vmax index before | 0.8979 | 0.8253–0.9768 | ≤44.6 | 81.3 | 75 | 0.0122 | |
| LA Vmin before | 0.9149 | 0.8571–0.9765 | ≤55.8 | 81 | 75 | 0.0075 | |
| LA EF before | 1.0757 | 1.0040–1.1526 | ≥36.2 | 62 | 87 | 0.0381 | |
A = late diastolic mitral inflow velocity; CI = confidence interval; COV = coefficient of variance; E = early diastolic mitral inflow velocity; EF = ejection fraction; LA = left atrium; Vmax = maximal volume; Vmin = minimal volume.
Figure 5Receiver operating characteristics (ROC) curves showing sensitivity and specificity left atrium maximal volume (left panel), left atrium diameter (right panel) in predicting cardiac resynchronization therapy response.